Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Understand the key aspects of points and cash back rewards. Equip yourself with knowledge to maximize your benefits.
28,655 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A longtime dividend grower is resurfacing in the spotlight after a 25% price pullback. With a higher-than-Treasury yi...
Fortune Brands Innovations stunned investors with a leadership overhaul after a zero-day CEO exit yielded $18.4 milli...
A top Nomura strategist says equities are priced for chaos, but the odds of a sweeping market crash remain low as dat...
A new HMDA analysis reveals a wide gap between DPA-eligible borrowers and actual users, underscoring outreach and acc...
As Kevin Warsh opens his first Federal Reserve meeting, AMD sits near all-time highs. Analysts and traders weighing e...
Qualcomm unveils a bold AI-backed diversification plan led by CIO Attila Tinic, targeting data centers, automotive an...
When a CFO sells a notable chunk of stock, investors want clarity. This article breaks down what CoreWeave's sold com...
XRP is hovering around $1.10 with steady buying activity backing a high weekly volume. While the price sits tight, tr...
Bitcoin remains range-bound near the $59K area as buyers defend the $58K-$60K zone, but a decisive move higher is not...
As volatility persists in 2026, a small-cap dividend ETF is drawing renewed interest from retirees seeking steady inc...
This original millionaire interview-style guide dives into the daily habits, smart choices, and concrete steps that h...